增强的VEGF信号通过下调导向蛋白ROBO4介导糖尿病大鼠脑内新生血管形成
研究在2型糖尿病Goto-Kakizaki(GK)大鼠中探讨VEGF信号与ROBO4的关系。发现糖尿病时脑血管及脑微血管内皮细胞ROBO4表达显著降低(p<0.05),ROBO4过表达可抑制VEGF诱导的血管生成信号并促进血管成熟;VEGFR-2拮抗剂SKLB1002增加ROBO4表达(p<0.05)并减少新生血管指数(p<0.05)。作者认为恢复ROBO4和抑制VEGF信号是糖尿病脑新生血管化的治疗策略。
要点
- 糖尿病GK大鼠脑血管及脑微血管内皮细胞ROBO4表达显著降低(p<0.05)。
- ROBO4过表达抑制VEGF诱导的血管生成信号并增加血管成熟。
- SKLB1002增加ROBO4表达(p<0.05)并减少新生血管指数(p<0.05)。
核心结论
- 恢复ROBO4表达和抑制VEGF信号被作者认定为糖尿病诱导脑新生血管化的治疗策略。
研究设计与样本
- 研究使用2型糖尿病Goto-Kakizaki(GK)大鼠模型,通过蛋白质印迹和免疫组化检测ROBO4蛋白表达。
- 在脑内及原代脑微血管内皮细胞(BMVECs)中局部过表达ROBO4,并用选择性VEGFR-2拮抗剂SKLB1002处理GK大鼠。
- 采用FITC血管空间填充模型测定脑血管新生指数,用免疫沉淀法检测ROBO4与β3整合素的相互作用。
主要发现
- 糖尿病时脑血管及BMVECs中ROBO4表达显著降低(p<0.05)。
- 沉默Robo4增加对照BMVECs的血管生成特性(p<0.05)。
- 体内和体外过表达ROBO4抑制VEGF诱导的血管生成信号并增加血管成熟。
- SKLB1002增加ROBO4表达(p<0.05)并减少新生血管指数(p<0.05)。
- SKLB1002显著降低糖尿病时ROBO4与β3整合素的相互作用(p<0.05)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Diabetes promotes cerebral neovascularisation via increased vascular endothelial growth factor (VEGF) angiogenic signalling. Roundabout-4 (ROBO4) protein is an endogenous inhibitor of VEGF signalling that stabilises the vasculature. Yet, how diabetes affects ROBO4 function remains unknown. We hypothesised that increased VEGF signalling in diabetes decreases ROBO4 expression and function via binding of ROBO4 with VEGF-activated β3 integrin and that restoration of ROBO4 expression prevents/repairs cerebral neovascularisation in diabetes. METHODS: ROBO4 protein expression in a rat model of type 2 diabetes (Goto-Kakizaki [GK] rats) was examined by western blotting and immunohistochemistry. ROBO4 was locally overexpressed in the brain and in primary brain microvascular endothelial cells (BMVECs). GK rats were treated with SKLB1002, a selective VEGF receptor-2 (VEGFR-2) antagonist. Cerebrovascular neovascularisation indices were determined using a FITC vascular space-filling model. Immunoprecipitation was used to determine ROBO4-β3 integrin interaction. RESULTS: ROBO4 expression was significantly decreased in the cerebral vasculature as well as in BMVECs in diabetes (p < 0.05). Silencing Robo4 increased the angiogenic properties of control BMVECs (p < 0.05). In vivo and in vitro overexpression of ROBO4 inhibited VEGF-induced angiogenic signalling and increased vessel maturation. Inhibition of VEGF signalling using SKLB1002 increased ROBO4 expression (p < 0.05) and reduced neovascularisation indices (p < 0.05). Furthermore, SKLB1002 significantly decreased ROBO4-β3 integrin interaction in diabetes (p < 0.05). CONCLUSIONS/INTERPRETATION: Our study identifies the restoration of ROBO4 and inhibition of VEGF signalling as treatment strategies for diabetes-induced cerebral neovascularisation.
引用
- Abdelsaid M, Coucha M, Hafez S, et al. Enhanced VEGF signalling mediates cerebral neovascularisation via downregulation of guidance protein ROBO4 in a rat model of diabetes. Diabetologia. 2017. PMID: 28116460. doi:10.1007/s00125-017-4214-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。